Mengjie Li
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Medicine top 5%
Papers in
-
- Metabolomics and Mass Spectrometry Studies 11
- RNA modifications and cancer 8
- Oncology 29
- Co-authors
- Chenxia Hu (7 shared papers)Linsheng Liu (10 shared papers)Jian Shi (9 shared papers)Jiye Aa (9 shared papers)Tianhua Zhou (5 shared papers)Wei Zhuo (5 shared papers)Bei Cao (9 shared papers)Guangji Wang (9 shared papers)
- Journals
- PLoS ONE (4 papers)Scientific Reports (4 papers)Molecules (3 papers)Occupational and Environmental Medicine (3 papers)BMC Cancer (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Mengjie Li
147 papers receiving 3.0k citations
Mengjie Li's Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 650
- Molecular Medicine 117
- Molecular Biology 1.6k
- Biological Psychiatry 35
- Oncology 331
Countries citing papers authored by Mengjie Li
This map shows the geographic impact of Mengjie Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengjie Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengjie Li more than expected).
Fields of papers citing papers by Mengjie Li
This network shows the impact of papers produced by Mengjie Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengjie Li. The network helps show where Mengjie Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Mengjie Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 166 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 206 | |
| 2 | Fusobacterium nucleatum reduces METTL3-mediated m6A modification and contributes to colorectal cancer metastasis Hit paper breakdown → | 2022 | 175 |
| 3 | 2018 | 115 | |
| 4 | 2010 | 113 | |
| 5 | 2016 | 110 | |
| 6 | 2019 | 103 | |
| 7 | 2015 | 102 | |
| 8 | 2018 | 90 | |
| 9 | 2013 | 79 | |
| 10 | 2021 | 76 | |
| 11 | 2016 | 73 | |
| 12 | 2013 | 65 | |
| 13 | 2018 | 60 | |
| 14 | 2021 | 53 | |
| 15 | 2020 | 50 | |
| 16 | 2019 | 48 | |
| 17 | 2012 | 44 | |
| 18 | 2016 | 43 | |
| 19 | 2018 | 41 | |
| 20 | 2017 | 39 |
About Mengjie Li
Mengjie Li is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 166 papers that have together received 3.1k indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (11 papers), RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (7 papers), Nanoplatforms for cancer theranostics (7 papers), Cancer, Hypoxia, and Metabolism (6 papers), Photodynamic Therapy Research Studies (5 papers) and Esophageal Cancer Research and Treatment (5 papers). The work is most often cited by research in Cancer Research (650 citations), Molecular Medicine (117 citations), Molecular Biology (1.6k citations), Biological Psychiatry (35 citations) and Oncology (331 citations). Mengjie Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Chenxia Hu, Linsheng Liu, Jian Shi, Jiye Aa, Tianhua Zhou, Wei Zhuo, Bei Cao, Guangji Wang, Tingting Guo and Sukyung Woo. Their work appears in journals such as PLoS ONE, Scientific Reports, Molecules, Occupational and Environmental Medicine and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.